retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism β±οΈπ How Fast Does Work? What the Clinical Data Shows π¬π Retatrutide is a next-generation triple-agonist therapy targeting GLP-1, GIP, and receptors designed to accelerate fat loss and metabolic improvement retatrutide mechanism glp-1 gip glucagon
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18






![Tirzepatide vs. Semaglutide: Which GLP-1 Better Preserves Muscle? [SURMOUNT-5 Data]](https://www.clinicalnutritioncenter.com/wp-content/uploads/2026/04/research-image-2026-04-10-1024x559.jpg)


















